US Stock MarketDetailed Quotes

Propanc Biopharma (PPCB)

Watchlist
  • 0.1063
  • -0.0043-3.89%
Close Apr 16 15:59 ET
  • 0.1003
  • -0.0060-5.64%
Post 19:59 ET
1.69MMarket Cap-0.02P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Propanc Biopharma (PPCB) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Dec 31, 2025
(Q1)Sep 30, 2025
(FY)Jun 30, 2025
(Q4)Jun 30, 2025
(Q3)Mar 31, 2025
(Q2)Dec 31, 2024
(Q1)Sep 30, 2024
(FY)Jun 30, 2024
(Q4)Jun 30, 2024
(Q3)Mar 31, 2024
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
1,612.77%3.65M
1,507.20%4.67M
3,628.93%57.28M
1,302.56%3.65M
12,523.63%53.13M
-51.29%213.38K
-30.30%290.79K
-13.54%1.54M
24.00%259.9K
8.97%420.87K
Selling and administrative expenses
2,186.11%3.63M
1,913.90%4.61M
4,329.87%57.05M
1,630.88%3.59M
14,832.97%53.07M
-50.93%158.99K
-42.87%229.08K
-15.75%1.29M
1.77%207.51K
11.00%355.42K
-General and administrative expense
2,186.11%3.63M
1,913.90%4.61M
4,329.87%57.05M
1,630.88%3.59M
14,832.97%53.07M
-50.93%158.99K
-42.87%229.08K
-15.75%1.29M
1.77%207.51K
11.00%355.42K
Research and development costs
-63.30%19.96K
-2.45%60.2K
-9.83%223.72K
2.16%53.52K
-17.34%54.1K
-52.30%54.39K
279.97%61.71K
0.07%248.1K
819.77%52.39K
-0.87%65.45K
Operating profit
-1,612.77%-3.65M
-1,507.20%-4.67M
-3,628.93%-57.28M
-1,302.56%-3.65M
-12,523.63%-53.13M
51.29%-213.38K
30.30%-290.79K
13.54%-1.54M
-24.00%-259.9K
-8.97%-420.87K
Net non-operating interest income expense
50.47%-58.92K
-254.44%-305.63K
15.33%-563.75K
-182.80%-254.54K
21.84%-104.04K
55.02%-118.94K
51.62%-86.23K
-24.96%-665.78K
21.21%-90K
15.32%-133.11K
Non-operating interest income
--37
1,800.00%19
-85.00%9
--7
-96.30%1
--0
-94.12%1
66.67%60
--0
237.50%27
Non-operating interest expense
-50.43%58.96K
254.46%305.65K
-15.33%563.76K
182.81%254.54K
-21.86%104.04K
-55.02%118.94K
-51.62%86.23K
24.97%665.84K
-21.22%90K
-15.31%133.14K
Other net income (expense)
735.88%622.26K
522.91%141.46K
-528.85%-1.08M
-1,826.39%-171.68K
-3,190.39%-834.59K
-832.51%-97.86K
-90.71%22.71K
152.43%252.17K
97.89%-8.91K
110.07%27.01K
Gain on sale of security
936.85%661.94K
-259.88%-54.41K
-206.47%-210.39K
-289.06%-140.68K
-172.92%-24.64K
-669.22%-79.1K
-83.82%34.03K
137.68%197.61K
91.32%-36.16K
113.13%33.79K
Special income (charges)
176.32%14.32K
1,830.37%195.86K
-1,696.32%-871.03K
-213.77%-31K
-11,844.46%-809.95K
-8,790.52%-18.76K
-132.99%-11.32K
25.53%54.57K
538.27%27.25K
36.77%-6.78K
-Less:Other special charges
-176.32%-14.32K
-1,830.37%-195.86K
1,696.32%871.03K
213.77%31K
11,844.46%809.95K
8,790.52%18.76K
132.99%11.32K
-25.53%-54.57K
-538.27%-27.25K
-36.77%6.78K
Other non- operating income (expenses)
---54K
----
----
----
----
----
----
----
----
----
Income before tax
-618.62%-3.09M
-1,265.40%-4.84M
-2,922.23%-58.92M
-1,034.70%-4.07M
-10,159.95%-54.07M
39.67%-430.18K
-0.98%-354.31K
30.13%-1.95M
51.96%-358.82K
35.06%-526.98K
Income tax
0
0
0
0
0
0
0
0.55%-129.13K
-119.82%-237
83.97%-275
Net income
-618.62%-3.09M
-1,265.40%-4.84M
-3,136.60%-58.92M
-1,035.45%-4.07M
-10,165.30%-54.07M
26.39%-430.18K
-0.98%-354.31K
31.57%-1.82M
52.06%-358.58K
34.96%-526.7K
Net income continuous Operations
-618.62%-3.09M
-1,265.40%-4.84M
-3,136.60%-58.92M
-1,035.45%-4.07M
-10,165.30%-54.07M
26.39%-430.18K
-0.98%-354.31K
31.57%-1.82M
52.06%-358.58K
34.96%-526.7K
Minority interest income
Net income attributable to the parent company
-618.62%-3.09M
-1,265.40%-4.84M
-3,136.60%-58.92M
-1,035.45%-4.07M
-10,165.30%-54.07M
26.39%-430.18K
-0.98%-354.31K
31.57%-1.82M
52.06%-358.58K
34.96%-526.7K
Preferred stock dividends
Other preferred stock dividends
932.25K
0
0
0
0
0
-58.62%192.96K
0
15.8K
Net income attributable to common stockholders
-835.33%-4.02M
-1,265.40%-4.84M
-2,826.43%-58.92M
-1,035.45%-4.07M
-9,866.33%-54.07M
30.50%-430.18K
28.20%-354.31K
35.61%-2.01M
55.50%-358.58K
33.01%-542.5K
Basic earnings per share
99.07%-0.3
99.86%-0.39
98.95%-14.85
99.22%-0.3506
95.79%-12.5
96.87%-32.23
85.60%-287.76
95.46%-1.42K
99.44%-44.9346
98.42%-296.7724
Diluted earnings per share
99.07%-0.3
99.86%-0.39
98.95%-14.85
99.22%-0.3506
95.79%-12.5
96.87%-32.23
85.60%-287.76
95.46%-1.42K
99.44%-44.9346
98.42%-296.7724
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Dec 31, 2025(Q1)Sep 30, 2025(FY)Jun 30, 2025(Q4)Jun 30, 2025(Q3)Mar 31, 2025(Q2)Dec 31, 2024(Q1)Sep 30, 2024(FY)Jun 30, 2024(Q4)Jun 30, 2024(Q3)Mar 31, 2024
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 1,612.77%3.65M1,507.20%4.67M3,628.93%57.28M1,302.56%3.65M12,523.63%53.13M-51.29%213.38K-30.30%290.79K-13.54%1.54M24.00%259.9K8.97%420.87K
Selling and administrative expenses 2,186.11%3.63M1,913.90%4.61M4,329.87%57.05M1,630.88%3.59M14,832.97%53.07M-50.93%158.99K-42.87%229.08K-15.75%1.29M1.77%207.51K11.00%355.42K
-General and administrative expense 2,186.11%3.63M1,913.90%4.61M4,329.87%57.05M1,630.88%3.59M14,832.97%53.07M-50.93%158.99K-42.87%229.08K-15.75%1.29M1.77%207.51K11.00%355.42K
Research and development costs -63.30%19.96K-2.45%60.2K-9.83%223.72K2.16%53.52K-17.34%54.1K-52.30%54.39K279.97%61.71K0.07%248.1K819.77%52.39K-0.87%65.45K
Operating profit -1,612.77%-3.65M-1,507.20%-4.67M-3,628.93%-57.28M-1,302.56%-3.65M-12,523.63%-53.13M51.29%-213.38K30.30%-290.79K13.54%-1.54M-24.00%-259.9K-8.97%-420.87K
Net non-operating interest income expense 50.47%-58.92K-254.44%-305.63K15.33%-563.75K-182.80%-254.54K21.84%-104.04K55.02%-118.94K51.62%-86.23K-24.96%-665.78K21.21%-90K15.32%-133.11K
Non-operating interest income --371,800.00%19-85.00%9--7-96.30%1--0-94.12%166.67%60--0237.50%27
Non-operating interest expense -50.43%58.96K254.46%305.65K-15.33%563.76K182.81%254.54K-21.86%104.04K-55.02%118.94K-51.62%86.23K24.97%665.84K-21.22%90K-15.31%133.14K
Other net income (expense) 735.88%622.26K522.91%141.46K-528.85%-1.08M-1,826.39%-171.68K-3,190.39%-834.59K-832.51%-97.86K-90.71%22.71K152.43%252.17K97.89%-8.91K110.07%27.01K
Gain on sale of security 936.85%661.94K-259.88%-54.41K-206.47%-210.39K-289.06%-140.68K-172.92%-24.64K-669.22%-79.1K-83.82%34.03K137.68%197.61K91.32%-36.16K113.13%33.79K
Special income (charges) 176.32%14.32K1,830.37%195.86K-1,696.32%-871.03K-213.77%-31K-11,844.46%-809.95K-8,790.52%-18.76K-132.99%-11.32K25.53%54.57K538.27%27.25K36.77%-6.78K
-Less:Other special charges -176.32%-14.32K-1,830.37%-195.86K1,696.32%871.03K213.77%31K11,844.46%809.95K8,790.52%18.76K132.99%11.32K-25.53%-54.57K-538.27%-27.25K-36.77%6.78K
Other non- operating income (expenses) ---54K------------------------------------
Income before tax -618.62%-3.09M-1,265.40%-4.84M-2,922.23%-58.92M-1,034.70%-4.07M-10,159.95%-54.07M39.67%-430.18K-0.98%-354.31K30.13%-1.95M51.96%-358.82K35.06%-526.98K
Income tax 00000000.55%-129.13K-119.82%-23783.97%-275
Net income -618.62%-3.09M-1,265.40%-4.84M-3,136.60%-58.92M-1,035.45%-4.07M-10,165.30%-54.07M26.39%-430.18K-0.98%-354.31K31.57%-1.82M52.06%-358.58K34.96%-526.7K
Net income continuous Operations -618.62%-3.09M-1,265.40%-4.84M-3,136.60%-58.92M-1,035.45%-4.07M-10,165.30%-54.07M26.39%-430.18K-0.98%-354.31K31.57%-1.82M52.06%-358.58K34.96%-526.7K
Minority interest income
Net income attributable to the parent company -618.62%-3.09M-1,265.40%-4.84M-3,136.60%-58.92M-1,035.45%-4.07M-10,165.30%-54.07M26.39%-430.18K-0.98%-354.31K31.57%-1.82M52.06%-358.58K34.96%-526.7K
Preferred stock dividends
Other preferred stock dividends 932.25K00000-58.62%192.96K015.8K
Net income attributable to common stockholders -835.33%-4.02M-1,265.40%-4.84M-2,826.43%-58.92M-1,035.45%-4.07M-9,866.33%-54.07M30.50%-430.18K28.20%-354.31K35.61%-2.01M55.50%-358.58K33.01%-542.5K
Basic earnings per share 99.07%-0.399.86%-0.3998.95%-14.8599.22%-0.350695.79%-12.596.87%-32.2385.60%-287.7695.46%-1.42K99.44%-44.934698.42%-296.7724
Diluted earnings per share 99.07%-0.399.86%-0.3998.95%-14.8599.22%-0.350695.79%-12.596.87%-32.2385.60%-287.7695.46%-1.42K99.44%-44.934698.42%-296.7724
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes----
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +6.33%
Sample Name
Sample Code
 +4.40%
Sample Name
Sample Code
 +3.43%
4
United States Gasoline Fund Lp
UGA
+0.46%
5
United Sts 12 Month Oil Fd Lp Unit Ben Int
USL
-1.17%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +17.08%
Sample Name
Sample Code
 +16.18%
Sample Name
Sample Code
 +15.82%
4
Baidu
BIDU
+15.52%
5
Zai Lab
ZLAB
+13.31%
View More
Middle East conflict spreads to the stock market! How should investors respond?
Trump stated on the 15th that the US-Iran war is 'about to end,' with an agreement expected to be reached before the end of April. However, Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -